ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Dicyclohexylcarbodiimide → 3-(4-(4-(3-(1-Triphenylmethyl-4-imidazolyl)propanoyl)-piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one

HRID 1167444
ノート
印刷プレビュー

反応式

HRID 1167444 の反応式
[C:1]1([C:7]([C:24]2[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=2)([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=2)[N:8]2[CH:12]=[C:11]([CH2:13][CH2:14][C:15](O)=[O:16])[N:10]=[CH:9]2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.C1(N=C=NC2CCCCC2)CCCCC1.ON1C2C=CC=CC=2N=N1.Cl.Cl.[N:57]1([C:63]2[CH:68]=[CH:67][C:66]([N:69]3[CH2:73][C@H:72]([CH2:74][O:75][C:76]4[CH:80]=[CH:79][O:78][N:77]=4)[O:71][C:70]3=[O:81])=[CH:65][C:64]=2[F:82])[CH2:62][CH2:61][NH:60][CH2:59][CH2:58]1.C(N(CC)C(C)C)(C)C>ClCCl>[C:24]1([C:7]([C:1]2[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=2)([C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][CH:23]=2)[N:8]2[CH:12]=[C:11]([CH2:13][CH2:14][C:15]([N:60]3[CH2:59][CH2:58][N:57]([C:63]4[CH:68]=[CH:67][C:66]([N:69]5[CH2:73][C@H:72]([CH2:74][O:75][C:76]6[CH:80]=[CH:79][O:78][N:77]=6)[O:71][C:70]5=[O:81])=[CH:65][C:64]=4[F:82])[CH2:62][CH2:61]3)=[O:16])[N:10]=[CH:9]2)[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 10868DicyclohexylcarbodiimideHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 74084421-(Triphenylmethyl)-1H-imidazole-4-propanoic acidHCID 69980303HCID 69980303、化合物

生成物 1

HCID 69979912
3-(4-(4-(3-(1-Triphenylmethyl-4-imidazolyl)propanoyl)-piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one
収率 63.3%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒2 回

実験手順

3-(1-Triphenylmethyl-4-imidazolyl)propionic acid (420 mg, 1.1 mmol) was suspended in dichloromethane (10 ml) under nitrogen, and treated successively with dicyclohexylcarbodiimide (227 mg, 1.1 mmol) and 1-hydroxybenzotriazole (149 mg, 1.1 mmol), then stirred at ambient temperature for 30 minutes. To it was added a solution of 3-(4-(piperazin-1-yl)-3-fluorophenyl)-5(R)-(isoxazol-3-yloxymethyl)oxazolidin-2-one dihydrochloride (435 mg, 1 mmol) and N,N-diisopropylethylamine (258 mg, 2 mmol) in dichloromethane (5 ml). The mixture was stirred for 18 hours at the same temperature, solid filtered off, and the organic phase purified by chromatography on a 20 g silica Mega Bond Elut® column, eluting with a gradient increasing in polarity from 0 to 15% MeOH in dichloromethane. Relevant fractions were combined and evaporated to give the desired product (460 mg).

後処理

  1. stirringThe mixture was stirred for 18 hours at the same temperature, solid
  2. filtrationfiltered off
  3. customthe organic phase purified by chromatography on a 20 g silica Mega Bond Elut® column
  4. washeluting with a gradient
  5. temperatureincreasing in polarity from 0 to 15% MeOH in dichloromethane
  6. customevaporated

出典と根拠

ORDレコード
ord-7d8f8c6bc6074053b9263a9b09300f61
出典データセット
uspto-grants-2003_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06617339B1

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート